Aytu Biopharma (AYTU) Cash from Operations (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly Cash from Operations of 4182000.0 for Q1 2026, up 35.21% year-over-year from 3092897.57 in Q1 2025, and down 213.8% quarter-over-quarter from 3675000.0 in Q4 2025.
Aytu Biopharma (AYTU) Cash from Operations (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Cash from Operations for 17 consecutive years, with 4182000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 35.21% year-over-year to 4182000.0; the TTM figure through Mar 2026 stood at 1678000.0 (up 130.35% YoY), while the FY2025 annual figure was 1937000.0, down 39.55% from the prior year.
- Cash from Operations declined to 4182000.0 in Q1 2026 per AYTU's latest filing, from 3675000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 9371000.0 in Q2 2023 and bottomed at 9115000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 1517000.0 across 5 years, with a median of 788000.0 in 2024.
- Annual changes were most pronounced in 2024 — Cash from Operations surged 2251.85% — and 2025, when it tumbled 2441.34%.
- Aytu Biopharma's Cash from Operations stood at 2488000.0 in 2022, then surged by 94.57% to 135000.0 in 2023, then soared by 2251.85% to 2905000.0 in 2024, then increased by 26.51% to 3675000.0 in 2025, then sank by 213.8% to 4182000.0 in 2026.
- Business Quant data shows AYTU's Cash from Operations at 4182000.0 in Q1 2026, 3675000.0 in Q4 2025, and 618000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | -4.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.18 Mn |
| Mar 31, 2026 | -4.18 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Dec 31, 2025 | 3.68 Mn |
| Sep 30, 2025 | -618,000.00 |
| Sep 30, 2025 | -618,000.00 |
| Jun 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 2.80 Mn |
| Mar 31, 2025 | -6.46 Mn |
| Mar 31, 2025 | -6.46 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Jun 30, 2024 | -788,000.00 |
| Jun 30, 2024 | -788,000.00 |
| Mar 31, 2024 | -254,000.00 |
| Mar 31, 2024 | -254,000.00 |
| Dec 31, 2023 | -135,000.00 |
| Dec 31, 2023 | -135,000.00 |